HIV in people who use drugs 2 Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed

被引:331
作者
Degenhardt, Louisa [1 ]
Mathers, Bradley [1 ]
Vickerman, Peter [4 ]
Rhodes, Tim [2 ,5 ]
Latkin, Carl [3 ]
Hickman, Matt [4 ]
机构
[1] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia
[2] London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1, England
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Univ Bristol, Dept Social Med, Bristol, Avon, England
[5] Univ New S Wales, Natl Ctr HIV Social Res, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; RISK BEHAVIORS; HARM REDUCTION; HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; SYRINGE EXCHANGE; VIRAL LOAD;
D O I
10.1016/S0140-6736(10)60742-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individual-level approaches to prevention of HIV infection; review global and regional coverage of opioid substitution treatment, needle and syringe programmes, and antiretroviral treatment; model the effect of increased coverage and a combination of these three approaches on HIV transmission and prevalence in injecting drug users; and discuss evidence for structural-level interventions. Each intervention alone will achieve modest reductions in HIV transmission, and prevention of HIV transmission necessitates high-coverage and combined approaches. Social and structural changes are potentially beneficial components in a combined-intervention strategy, especially when scale-up is difficult or reductions in HIV transmission and injection risk are difficult to achieve. Although further evidence is needed on how to optimise combinations of interventions in different settings and epidemics, we know enough now about which actions are effective: the challenge is to deliver these well and to scale.
引用
收藏
页码:285 / 301
页数:17
相关论文
共 149 条
[1]   Housing status and HIV risk behaviors: Implications for prevention and policy [J].
Aidala, A ;
Cross, JE ;
Stall, R ;
Harre, D ;
Sumartojo, E .
AIDS AND BEHAVIOR, 2005, 9 (03) :251-265
[2]   An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research [J].
Amato, L ;
Davoli, M ;
Perucci, CA ;
Ferri, M ;
Faggiano, F ;
Mattick, RP .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2005, 28 (04) :321-329
[3]   Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification (Withdrawn Paper, art. no. CD005031, 2008) [J].
Amato, Laura ;
Minozzi, Silvia ;
Davoli, Marina ;
Vecchi, Simona ;
Ferri, Marica M. F. ;
Mayet, Soraya .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03)
[4]   A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility [J].
Andresen, Martin A. ;
Boyd, Neil .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2010, 21 (01) :70-76
[5]  
[Anonymous], 2009, Progress Report'
[6]  
[Anonymous], CONS STAT ADDR KNOWL
[7]  
[Anonymous], 2009, ASSESSMENT COMPULSOR
[8]  
[Anonymous], PRIM PREV HEP C INJ
[9]  
[Anonymous], 2003, Final report on the evaluation of Sydney medically supervised injecting centre
[10]  
[Anonymous], 2010, DETENTION TREATMENT